Edward M. Schaeffer

African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?

A. Partin, Misop Han, E. Humphreys, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.

M. Cooperberg, B. Trock, E. Klein, 2018, European urology.

Reclassification rates are higher among African American men than Caucasians on active surveillance.

B. Trock, E. Schaeffer, A. Ross, 2015, Urology.

Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.

D. Sundi, Jonathan I. Epstein, H. Carter, 2014, The Journal of urology.

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes.

Katarzyna J Macura, Bruce J Trock, H Ballentine Carter, 2015, Urology.

Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.

M. Cooperberg, B. Trock, E. Klein, 2018, European urology.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

P. Carroll, R. Stoyanova, A. Tewari, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review

E. Schaeffer, C. Pettaway, D. Sundi, 2017, Prostate Cancer and Prostatic Diseases.

Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.

P. Choyke, J. Epstein, J. Tosoian, 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.